hyperuricemia
Conditions
Interventions
Chinese medicines group:None
Digital allied health care group:None
Sponsors
Tongji Hospital of Tongji University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Aged 18 to 65 years, regardless of gender; 2.Fasting blood uric acid level >= 420-660 µmol/L (7-11.0 mg/dL); 3.No previous history of gouty arthritis; 4.Not receiving drug treatment for hyperuricemia/stopping uric acid-lowering drug treatment for>=12 weeks; 5.Be able to understand and be willing to sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Hyperuricemia was first discovered. 2.Taking other drugs that affect uric acid metabolism in the past 12 weeks; 3.Past history of gouty arthritis; 4.Secondary hyperuricemia, such as: bone marrow and lymphoproliferative diseases, tumor radiotherapy and chemotherapy, liver cirrhosis and drug-induced hyperuricemia; 5.One of the following complications: hypertension, diabetes, stroke, coronary heart disease, severe liver and kidney function impairment (>=CKD2 stage, or creatinine, urea, glutalanine, glutoxalotransglutine >= 2 times the upper limit of clinical normal value); 6.Able to sign informed consent; 7.The compliance of patients participating in the study is poor, and the completion rate of baseline screening data is <=80%.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| uric acid; | — |
Secondary
| Measure | Time frame |
|---|---|
| routine urine test;height;weight;daily walks; | — |
Countries
China
Contacts
Public ContactGao Qin
Tongji Hospital of Tongji University
Outcome results
None listed